Log In
BCIQ
Print this Print this
 

Erythropoietin (EPO) receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Erythropoietin (EPO) receptor

BCIQ
Print ChartPrint this
13 - Hematology 1 - Hematology 1 - Cancer 1 - Neurology 1 - Neurology 4 - Hematology 2 - Hematology
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIMarketed
Cancer

-

-

-

1

-

Hematology

2

4

-

1

13

Neurology

-

1

1

-

-




 Products Targeting Erythropoietin (EPO) receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

8

$2,646.8M

$1,824.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today